PEStore

Venture Capital

Rhapsody Venture

Rhapsody Venture backs early-stage and high-growth companies, typically pre-profit, from United States. It states a focus on healthcare & life sciences, environmental & safety, software & internet and industrials & manufacturing.

Disclosed holdings42
Earliest stated investment
HeadquartersUnited States
Stated cheque size$500K-$2M

Regulatory record

How Rhapsody Venture is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised6 · $122m gross
SEC adviser numberCRD 309936

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies Rhapsody Venture lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
Adden
Addenenergy
Ambersi
Apeel
BTG Positioning Systems
Biophilica
ChEmpower
Chempower Corp
Chinova
Chinovabioworks
Cnergreen
Fluid Efficiency
GPR
Hazeltechnologies
Holiferm
HyperDamping
Kinalco
Lasso
Lassolabs
Latys
Liquiglide
Ltphotonics
Magnolia Medical
Manus Bio
NODAR
Netpreme
Nodarsensor
Nucicer
Nuclearturbines
Ph7technologies
Polariseo
Relativitynetworks
Safi Tech
Sensatek
Spindrive
Tendo
Tendo Technologies
Titan
Titanhaptics
Verdafresh
Vionano
Wavelogix

Compiled from Rhapsody Venture’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Rhapsody Venture?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other venture capital investors active in healthcare & life sciences.